Page 707 - Read Online

Page 10 of 10 Rodinò et al. Mini-invasive Surg 2020;4:70 I http://dx.doi.org/10.20517/2574-1225.2020.55

12. O’Gara P, Sugeng L, Lang R, Sarano M, Hung J, et al. The role of imaging in chronic degenerative mitral regurgitation. JACC Cardiovasc
Imaging 2008;1:221-37.
13. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, et al; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system:
safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol
2009;54:686-94.
14. Li CH, Arzamendi D, Carreras F. Role of imaging techniques in percutaneous treatment of mitral regurgitation. Rev Esp Cardiol (Engl
Ed) 2016;69:421-36.
15. Eggebrecht H, Schelle S, Puls M, Plicht B, von Bardeleben RS, et al. Risk and outcomes of complications during and after MitraClip
implantation: Experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheter
Cardiovasc Interv 2015;86:728-35.
16. Praz F, Spargias K, Chrissoheris M, Büllesfeld L, Nickenig G, et al. Compassionate use of the PASCAL transcatheter mitral valve repair
system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet 2017;390:773-80.
17. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, et al; EVEREST II Investigators. Percutaneous repair or surgery for mitral
regurgitation. N Engl J Med 2011;364:1395-406.
18. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, et al; EVEREST II investigators. Randomized comparison of percutaneous repair and
surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 2015;66:2844-54.
19. Buzzatti N, Van Hemelrijck M, Denti P, Ruggeri S, Schiavi D, et al. Transcatheter or surgical repair for degenerative mitral regurgitation
in elderly patients: a propensity-weighted analysis. J Thorac Cardiovasc Surg 2019;158:86-94.e1.
20. Lim DS, Reynolds MR, Feldman T, Kar S, Herrmann HC, et al. Improved functional status and quality of life in prohibitive surgical risk
patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 2014;64:182-92.
21. Jorbenadze R, Schreieck J, Barthel C, Seizer P, Schlensak C, et al. Percutaneous edge-to-edge mitral valve repair using the new MitraClip
XTR System. JACC Cardiovasc Interv 2018;11:e93-5.
22. Weinmann K, Markovic S, Rottbauer W, Keßler M. First experience with the MitraClip XTR device for extensive mitral valve prolapse
(Barlow’s disease). EuroIntervention 2018;14:e1276-7.
23. Lim DS, Kar S, Spargias K, Kipperman RM, O’Neill WW, et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day
results of the CLASP study. JACC Cardiovasc Interv 2019;12:1369-78.
24. Mazimba S, Lim SD, Kipperman R, Spargias K, Kar S, et al. Six-month outcomes from the multicenter, prospective study with the novel
PASCAL transcatheter valve repair system for patients with mitral regurgitation in the CLASP study. J Card Fail 2019;25:S6.
25. Kar S, Ng M, Lim S, Walters D, Webb J, et al. TCT-91 1-year outcomes from the multicenter, prospective study with the novel PASCAL
transcatheter valve repair system for patients with mitral regurgitation in the CLASP study. J Am Coll Cardiol 2019;74:B91.
26. Glower DD, Kar S, Trento A, Lim DS, Bajwa T, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients:
results of the EVEREST II study. J Am Coll Cardiol 2014;64:172-81.
27. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, et al. Percutaneous mitral valve interventions in the real world: early and 1-year
results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am
Coll Cardiol 2013;62:1052-61.
28. Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, et al; Transcatheter Valve Treatment Sentinel Registry
Investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge-to-
edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol
2014;64:875-84.
29. Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, et al. One-year outcomes and predictors of mortality after MitraClip
therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J
2016;37:703-12.
30. Capodanno D, Adamo M, Barbanti M, Giannini C, Laudisa ML, et al; GRASP-IT Investigators. Predictors of clinical outcomes after
edge-to-edge percutaneous mitral valve repair. Am Heart J 2015;170:187-95.
31. Sorajja P, Vemulapalli S, Feldman T, Mack M, Holmes DR Jr, et al. Outcomes with transcatheter mitral valve repair in the United States:
an STS/ACC TVT registry report. J Am Coll Cardiol 2017;70:2315-27.
32. Sürder D, Pedrazzini G, Gaemperli O, Biaggi P, Felix C, et al. Predictors for efficacy of percutaneous mitral valve repair using the
MitraClip system: the results of the MitraSwiss registry. Heart 2013;99:1034-40.